not tagged
bms,eisai pharmaceutical
['ovarian', 'bms', 'bmsnews', 'eisai']
japanese #pharma eisai reports preliminary data at #asco22 for its adc for fr -positive ovarian cancer, licensed for $650m upfront by a year ago 
https://t.co/O0ZJQGMjEP, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate